| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |